![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the trea... Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease. Show more
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -15.88 | -91.8981481481 | 17.28 | 17.28 | 16.56 | 206710 | 16.8 | CS |
4 | -16.24 | -92.0634920635 | 17.64 | 18.36 | 16.56 | 204350 | 17.47925563 | CS |
12 | -14.2 | -91.0256410256 | 15.6 | 18.42 | 14.04 | 224474 | 16.16022247 | CS |
26 | -15.16 | -91.5458937198 | 16.56 | 18.42 | 12.12 | 265433 | 15.63379687 | CS |
52 | -9.4 | -87.037037037 | 10.8 | 19.8 | 10.5612 | 477379 | 16.64876174 | CS |
156 | -132.64 | -98.955535661 | 134.04 | 134.04 | 6.72 | 679020 | 21.01538071 | CS |
260 | -176.8 | -99.214365881 | 178.2 | 351.84 | 6.72 | 548958 | 64.4096614 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions